UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 139

Sortiert nach

Establishing a robust radioligand therapy program: A practical approach for North American centers

Cancer medicine (Malden, MA), 2024-02, Vol.13 (3), p.e6780-n/a

2024

Link zum Volltext

Verfügbarkeit prüfen

Clinical [18F]FSPG Positron Emission Tomography Imaging Reveals Heterogeneity in Tumor-Associated System xc− Activity

Cancers, 2024-04, Vol.16 (7), p.1437

2024

Link zum Volltext

Verfügbarkeit prüfen

Preclinical Efficacy of the Anti-Hepatocyte Growth Factor Antibody Ficlatuzumab in a Mouse Brain Orthotopic Glioma Model Evaluated by Bioluminescence, PET, and MRI

Clinical cancer research, 2013-10, Vol.19 (20), p.5711-5721

2013

Link zum Volltext

Verfügbarkeit prüfen

Initial evaluation of (4S)-4-(3-[18F]fluoropropyl)-l-glutamate (FSPG) PET/CT imaging in patients with head and neck cancer, colorectal cancer, or non-Hodgkin lymphoma

EJNMMI research, 2020-08, Vol.10 (1), p.100-100, Article 100

2020

Link zum Volltext

Verfügbarkeit prüfen

Neuroendocrine Tumor Therapy: 177 Lu-DOTATATE

American journal of roentgenology (1976), 2018-08, Vol.211 (2), p.278

Mittra, Erik S

2018

Link zum Volltext

Verfügbarkeit prüfen

SNMMI Procedure Standard/EANM Practice Guideline for SSTR PET: Imaging Neuroendocrine Tumors

Journal of Nuclear Medicine, 2023-02, Vol.64 (2), p.204-210

2023

Link zum Volltext

Verfügbarkeit prüfen

Comparative morphometrics of the primate apical tuft

American journal of physical anthropology, 2007-12, Vol.134 (4), p.449-459

2007

Link zum Volltext

Verfügbarkeit prüfen

The State of Peptide Receptor Radionuclide Therapy and Its Sequencing among Current Therapeutic Options for Gastroenteropancreatic Neuroendocrine Tumors

Neuroendocrinology, 2021-10, Vol.111 (11), p.1086-1098

2021

Link zum Volltext

Verfügbarkeit prüfen

Consideration of quality of life in the treatment decision-making for patients with advanced gastroenteropancreatic neuroendocrine tumors

Expert review of anticancer therapy, 2023-06, Vol.23 (6), p.601-615

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinical Evaluation of (4S)-4-(3-[ 18 F]Fluoropropyl)-L-glutamate ( 18 F-FSPG) for PET/CT Imaging in Patients with Newly Diagnosed and Recurrent Prostate Cancer

Clinical cancer research, 2020-10, Vol.26 (20), p.5380-5387

2020

Link zum Volltext

Verfügbarkeit prüfen

18F-FSPG PET/CT Imaging of System xC- Transporter Activity in Patients with Primary and Metastatic Brain Tumors

Radiology, 2022-06, Vol.303 (3), p.620-631

2022

Link zum Volltext

Verfügbarkeit prüfen

18 F-FSPG PET/CT Imaging of System x C - Transporter Activity in Patients with Primary and Metastatic Brain Tumors

Radiology, 2022-06, Vol.303 (3), p.620-631

2022

Link zum Volltext

Verfügbarkeit prüfen

Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline

Journal of clinical oncology, 2023-11, Vol.41 (32), p.5049-5067

2023

Link zum Volltext

Verfügbarkeit prüfen

Exploratory Clinical Trial of (4S)-4-(3-[18F]fluoropropyl)-L-glutamate for Imaging xC― Transporter Using Positron Emission Tomography in Patients with Non―Small Cell Lung or Breast Cancer

Clinical cancer research, 2012-10, Vol.18 (19), p.5427-5437

2012

Link zum Volltext

Verfügbarkeit prüfen

Case 207: Hodgkin lymphoma with paraneoplastic hypercalcemic pancreatitis

Radiology, 2014-07, Vol.272 (1), p.296

2014

Link zum Volltext

Verfügbarkeit prüfen

Characterization of Physiologic (18)F FSPG Uptake in Healthy Volunteers

Radiology, 2016-06, Vol.279 (3), p.898

2016

Link zum Volltext

Verfügbarkeit prüfen

Spectrum of 68Ga-DOTA TATE Uptake in Patients With Neuroendocrine Tumors

Clinical nuclear medicine, 2016-06, Vol.41 (6), p.e281-e287

2016

Link zum Volltext

Verfügbarkeit prüfen

Standard OSEM vs. regularized PET image reconstruction: qualitative and quantitative comparison using phantom data and various clinical radiopharmaceuticals

American journal of nuclear medicine and molecular imaging, 2018-01, Vol.8 (2), p.110-118

2018

Link zum Volltext

Verfügbarkeit prüfen

Comparison Between Different PET and CT-Based Imaging Interpretation Criteria at Interim Imaging in Patients With Diffuse Large B-Cell Lymphoma

Clinical nuclear medicine, 2018-01, Vol.43 (1), p.1-8

2018

Link zum Volltext

Verfügbarkeit prüfen

NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy

The Journal of nuclear medicine (1978), 2020-02, Vol.61 (2), p.222-227

2020

Link zum Volltext

Verfügbarkeit prüfen

NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of 177 Lu-DOTATATE Peptide Receptor Radionuclide Therapy

Journal of Nuclear Medicine, 2020-02, Vol.61 (2), p.222-227

2020

Link zum Volltext

Verfügbarkeit prüfen

Fusion dual-tracer SPECT-based hepatic dosimetry predicts outcome after radioembolization for a wide range of tumour cell types

European journal of nuclear medicine and molecular imaging, 2015-07, Vol.42 (8), p.1192-1201

2015

Link zum Volltext

Verfügbarkeit prüfen

Biodistribution and Radiation Dosimetry of 18 F-FTC-146 in Humans

Journal of Nuclear Medicine, 2017-12, Vol.58 (12), p.2004-2009

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 139

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(134)
Mit Volltextzugriff
(123)

Publikationsform

Sprache

Englisch
(139)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Humans
(64)
Science & Technology
(46)
Female
(43)
Life Sciences & Biomedicine
(43)
Male
(39)
Middle Aged
(34)
Adult
(29)
Aged
(28)
Oncology
(25)
Radiology, Nuclear Medicine & Medical Imaging
(24)
Positron-Emission Tomography
(20)
Radiopharmaceuticals
(20)
Cancer
(18)
Fluorodeoxyglucose F18
(18)
Nuclear Medicine
(18)
Patients
(18)
Medical Imaging
(17)
Tomography, X-Ray Computed
(16)
Tumors
(16)
Aged, 80 And Over
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816

Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies

Establishing a robust radioligand therapy program: A practical approach for North American centers

Clinical [18F]FSPG Positron Emission Tomography Imaging Reveals Heterogeneity in Tumor-Associated System xc− Activity

Preclinical Efficacy of the Anti-Hepatocyte Growth Factor Antibody Ficlatuzumab in a Mouse Brain Orthotopic Glioma Model Evaluated by Bioluminescence, PET, and MRI

Initial evaluation of (4S)-4-(3-[18F]fluoropropyl)-l-glutamate (FSPG) PET/CT imaging in patients with head and neck cancer, colorectal cancer, or non-Hodgkin lymphoma

Neuroendocrine Tumor Therapy: 177 Lu-DOTATATE

SNMMI Procedure Standard/EANM Practice Guideline for SSTR PET: Imaging Neuroendocrine Tumors

Comparative morphometrics of the primate apical tuft

The State of Peptide Receptor Radionuclide Therapy and Its Sequencing among Current Therapeutic Options for Gastroenteropancreatic Neuroendocrine Tumors

Consideration of quality of life in the treatment decision-making for patients with advanced gastroenteropancreatic neuroendocrine tumors

Clinical Evaluation of (4S)-4-(3-[ 18 F]Fluoropropyl)-L-glutamate ( 18 F-FSPG) for PET/CT Imaging in Patients with Newly Diagnosed and Recurrent Prostate Cancer

18F-FSPG PET/CT Imaging of System xC- Transporter Activity in Patients with Primary and Metastatic Brain Tumors

18 F-FSPG PET/CT Imaging of System x C - Transporter Activity in Patients with Primary and Metastatic Brain Tumors

Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline

Exploratory Clinical Trial of (4S)-4-(3-[18F]fluoropropyl)-L-glutamate for Imaging xC― Transporter Using Positron Emission Tomography in Patients with Non―Small Cell Lung or Breast Cancer

Case 207: Hodgkin lymphoma with paraneoplastic hypercalcemic pancreatitis

Characterization of Physiologic (18)F FSPG Uptake in Healthy Volunteers

Spectrum of 68Ga-DOTA TATE Uptake in Patients With Neuroendocrine Tumors

Standard OSEM vs. regularized PET image reconstruction: qualitative and quantitative comparison using phantom data and various clinical radiopharmaceuticals

Comparison Between Different PET and CT-Based Imaging Interpretation Criteria at Interim Imaging in Patients With Diffuse Large B-Cell Lymphoma

NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy

NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of 177 Lu-DOTATATE Peptide Receptor Radionuclide Therapy

Fusion dual-tracer SPECT-based hepatic dosimetry predicts outcome after radioembolization for a wide range of tumour cell types

Biodistribution and Radiation Dosimetry of 18 F-FTC-146 in Humans

Suchergebnisse filtern